Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies

Journal of Clinical Oncology

Volumn 18, Issue 11, 2000, Pages 2210-2218

  Dawson, Laura A ^a   McGinn, Cornelius J ^a   Normolle, Daniel ^a   Ten Haken, Randall K ^a   Walker, Suzette ^a   Ensminger, William ^a   Lawrence, Theodore S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BILE DUCT OBSTRUCTION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; ERYTHEMA; ESOPHAGITIS; FEMALE; FEVER; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; HEPATIC ARTERY; HEPATOBILIARY SYSTEM CANCER; HUMAN; INFECTION; LIVER DISEASE; LIVER METASTASIS; LIVER TUMOR; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; VOMITING;

EID: 0034043535     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.11.2210     Document Type: Article

References (42)

1. O'Connell MJ, Nagorney DM, Bernath AM, et al: Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 16:2528-2533, 1998
2. Hughes KS, Simon R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: A multi-institutional study of patterns of recurrence. Surgery 100:278-284, 1986
3. Ingold J, Reed G, Kaplan H: Radiation hepatitis. Am J Roentgenol 93:200-208, 1965
4. Wharton JT, Delclos L, Gallager S, et al: Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117:73-80, 1973
5. Robertson JM, McGinn CJ, Walker S, et al: A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases. Int J Radiat Oncol Biol Phys 39:1087-1092, 1997
6. Robertson JM, Lawrence TS, Walker S, et al: The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy. Int J Radiat Oncol Biol Phys 32:445-450, 1995
7. Ohara K, Okumura T, Tsuji H, et al: Clearance of parenchymal tumors following radiotherapy: Analysis of hepatocellular carcinomas treated by proton beams. Radiother Oncol 41:233-236, 1996
8. Matsuzaki Y, Osuga T, Chiba T, et al: New, effective treatment using proton irradiation for unresectable hepatocellular carcinoma. Intern Med 34:302-304, 1995
9. Lawrence TS, Ten Haken RK, Kessler ML, et al: The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23:781-788, 1992
10. McGinn CJ, Ten Haken RK, Ensminger WD, et al: Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16:2246-2252, 1998
11. Balter JM, Lam KL, McGinn CJ, et al: Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging. Int J Radiat Oncol Biol Phys 41:939-943, 1998
12. Ten Haken RK, Martel MK, Kessler ML, et al: Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 27:689-695, 1993
13. Ensminger WD: Regional chemotherapy [review]. Semin Oncol 20:3-11, 1993
14. Fletcher G: Clinical dose-response curves of human malignant epithelial tumours. Br J Radiol 46:1-12, 1973
15. Robertson JM, Lawrence TS, Dworzanin LM, et al: Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy. J Clin Oncol 11:1286-1293, 1993
16. Robertson JM, Lawrence TS, Andrews JC, et al: Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers. Int J Radiat Oncol Biol Phys 37:325-330, 1997
17. Leibel SA, Pajak TF, Massullo V, et al: A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: Results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 13:1057-1064, 1987
18. Lawrence TS, Dworzanin LM, Walker-Andrews SC, et al: Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys 20:555-561, 1991
19. Russell AH, Clyde C, Wasserman TH, et al: Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: Results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 27:117-123, 1993
20. Mohiuddin M, Chen E, Ahmad N: Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer. J Clin Oncol 14:722-728, 1996
21. Seong J, Keum KC, Han KH, et al: Combined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 43:393-397, 1999
22. Blomgren H, Lax I, Naslund I, et al: Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator: Clinical experience of the first thirty-one patients. Acta Oncol 34:861-870, 1995
23. Matsuura M, Ishikawa A, Nakajima N, et al: Radical radiation therapy of hepatocellular carcinoma [Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 54:628-635, 1994
24. Zeng ZC, Tang ZY, Liu KD, et al: Improved long-term survival for unresectable hepatocellular carcinoma (HCC) with a combination of surgery and intrahepatic arterial infusion of 131I-anti-HCC mAb: Phase I/II clinical trials. J Cancer Res Clin Oncol 124:275-280, 1998
25. Ychou M, Pelegrin A, Faurous P, et al: Phase-I/II radioimmunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab′)2 in patients with non-resectable liver metastases from colorectal cancer. Int J Cancer 75:615-619, 1998
26. Abrams RA, Cardinale RM, Enger C, et al: Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: Experience with cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys 39:1077-1085, 1997
27. Raoul JL, Guyader D, Bretagne JF, et al: Prospective randomized trial of chemoembolization versus intra-arterial injection of 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma. Hepatology 26:1156-1161, 1997
28. Venook AP: Treatment of hepatocellular carcinoma: Too many options? [review] J Clin Oncol 12:1323-1334, 1994
29. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma [see comments]. N Engl J Med 332:1256-1261, 1995
30. Allgaier HP, Deibert P, Olschewski M, et al: Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection: A single-center analysis including 132 patients. Int J Cancer 79:601-605, 1998
31. Giorgio A, Tarantino L, Mariniello N, et al: Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients. Eur J Ultrasound 8:201-206, 1998
32. Pergolizzi JV Jr, Auster M, Conaway GL, et al: Cryosurgery for unresectable primary hepatocellular carcinoma: A case report and review of literature [review]. Am Surg 65:402-405, 1999
33. Sarantou T, Bilchik A, Ramming K: Cryoablation of primary and metastatic liver cancer unresponsive to conventional therapy. Proc Am Soc Clin Oncol 16:304a, 1997 (abstr 1082)
34. Murakami T, Shibata T, Ishida T, et al: Percutaneous microwave hepatic tumor coagulation with segmental hepatic blood flow occlusion in seven patients. AJR Am J Roentgenol 172:637-640, 1999
35. Rhim H, Dodd GD III: Radiofrequency thermal ablation of liver tumors [review]. J Clin Ultrasound 27:221-229, 1999
36. Cunningham D, Pyrhonen S, James RD, et al: Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [see comments]. Lancet 352:1413-1418, 1998
37. Rougier P, Van Cutsem E, Bajetta E, et al: Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer [see comments] [published erratum appears in Lancet 352:1634, 1998]. Lancet 352: 1407-1412, 1998
38. Wanebo H, Levy A: Alternating hepatic artery infusion of 5-fluorodeoxyuridine (FUdR), dexamethasone (dex) and leucovorin with systemic continuous infusion (CI) if 5-fluorouracil and leucovorin is associated with apparent survival benefit (median 18 months) in patients with unresectable liver metastases from colorectal cancer (CRC). Proc Am Soc Clin Oncol 17:271a, 1998 (abstr 1041)
39. Iop A, Cartei G, Mansutti M, et al: Hepatic arterial infusion (HAI) and systemic chemotherapy for unresectable liver metastases (LM) from colorectal carcinoma (CC). Proc Am Soc Clin Oncol 16:291a, 1997 (abstr 1036)
40. Kemeny N, Conti JA, Cohen A, et al: Phase II study of hepatic arterial floxuridine, leucovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 12:2288-2295, 1994
41. Findlay M, Hill A, Cunningham D, et al: Protracted venous infusion 5-fluorouracil and interferon-alpha in advanced and refractory colorectal cancer. Ann Oncol 5:239-243, 1994
42. Wong JW, Sharpe MB, Jaffray DA, et al: The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44:911-919, 1999